Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1993-1-27
pubmed:abstractText
The vimentin gene is a member of the intermediate filament multigene family and encodes a protein expressed, in vivo, in all mesenchymal derivatives and, in vitro, in cell types of various origin. We have previously demonstrated that the expression of this growth-regulated gene could be trans activated by the 40-kDa Tax protein of HTLV-I (human T-cell leukemia virus type I) and that responsiveness to this viral protein was mediated by the presence of an NF-kappa B binding site located between -241 and -210 bp upstream of the mRNA cap site (A. Lilienbaum, M. Duc Dodon, C. Alexandre, L. Gazzolo, and D. Paulin, J. Virol. 64:256-263, 1990). These previous assays, performed with deletion mutants of the vimentin promoter linked to the chloramphenicol acetyltransferase gene, also revealed the presence of an upstream negative region between -529 and -241 bp. Interestingly, the inhibitory activity exerted by this negative region was overcome after cotransfection of a Tax-expressing plasmid. In this study, we further characterize the vimentin negative element and define the effect of the Tax protein on the inhibitory activity of this element. We first demonstrate that a 187-bp domain (-424 to -237 bp) behaves as a negative region when placed upstream either of the NF-kappa B binding site of vimentin or of a heterologous enhancer such as that present in the desmin gene promoter. The negative effect can be further assigned to a 32-bp element which is indeed shown to repress the basal or induced activity of the NF-kappa B binding site.(ABSTRACT TRUNCATED AT 250 WORDS)
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-1316451, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-1849686, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-1996116, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-1999493, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2007603, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2170976, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2172963, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2293664, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2325656, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2358774, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2370857, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2370863, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2410921, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2462307, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2631796, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2665943, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2667136, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2847164, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-2854202, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-3005203, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-3011413, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-3011423, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-3037497, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-3037548, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-3053306, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-3431546, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-3755218, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-6261256, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-6330891, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-6828386, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-6960240, http://linkedlifedata.com/resource/pubmed/commentcorrection/8417364-6979048
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0270-7306
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
89-97
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Identification of a negative element in the human vimentin promoter: modulation by the human T-cell leukemia virus type I Tax protein.
pubmed:affiliation
UMR30 Centre National de la Recherche Scientifique/Université Claude Bernard Lyon I, Faculté de Médecine A. Carrel, France.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't